MTOR inhibition attenuates glucose deprivation-induced death in photoreceptors via suppressing a mitochondria-dependent apoptotic pathway. (October 2016)

• Record Type: Journal Article
• Authors: Fan, Bin; Li, Fu-Qaing; Zuo, Ling; Li, Guang-Yu
• Is Part Of: Neurochemistry international. Volume 99(2016)
• Page Start: 178
• Page End: 186
• Publication Date: 2016-10
• Subjects: mTOR -- Mitochondrial membrane potential -- Rapamycin -- Photoreceptor cells -- Oxidative stress -- DRP1; Neurochemistry -- Periodicals; Neurochemistry -- Periodicals; Neurochimie -- Périodiques; Neurochemistry; Periodicals; 612.804205
• DOI: 10.1016/j.neuint.2016.07.004
• Languages: English
• ISSNs: 0197-0186

Abstract

Abstract: Acute energy depletion contributes to ischemia-induced retinal neuronal injury, causing photoreceptor death and subsequent vision loss. The mTOR pathway is a crucial cellular signaling hub modulating RNA transcription, protein synthesis, and metabolic balance. Thus, we mimicked acute energy depletion in photoreceptor cells (661W cells) with glucose deprivation and investigated neuroprotective mechanisms of mTOR inhibition. We found that treatment with rapamycin, an mTOR-specific inhibitor, reduced intracellular ROS, maintained the mitochondrial membrane potential and restored mitochondrial dysfunction. In addition, inhibiting the mTOR signal suppressed DRP1 translocation to the mitochondria, pro-apoptotic mitochondrial protein release, and caspase 3 activation when glucose was deprived. Inhibition of mTOR offers significant neuroprotection against glucose deprivation-induced injury in 661W cells, chiefly via suppressing mitochondrial-dependent pathways. These observations may shed light on treating ischemia-related retinal diseases. Highlights: Inhibition of mTOR maintains mitochondrial function. Inhibition of mTOR suppresses DRP1 activation. Inhibition of mTOR attenuates activation of mitochondria-dependent pathways. Inhibition of mTOR attenuates GD-induced photoreceptor death.